Pembrolizumab in Combination With Intratumoral SD-101 Therapy

Condition:   Prostatic Neoplasms Interventions:   Drug: Pembrolizumab;   Drug: SD-101;   Radiation: High Dose Rate (HDR) Brachytherapy;   Other: Combined Androgen Blockage (CAB) Sponsor:   Lawrence Fong Not yet recruiting - verified December 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials